COVID-19
Scientists at Oak Ridge National Laboratory have designed a molecule that targets a lesser-studied enzyme in COVID-19 research, PLpro, which helps the coronavirus multiply and hampers the host body's immune response. The molecule, a covalent inhibitor, forms a strong chemical bond with its intended protein target and increases
COVID-19
Research conducted at Rutgers University - The State University of New Jersey has found that a mobile mindful meditation application can significantly reduce stress levels in healthcare workers during the COVID-19 pandemic. The study involved 100 participants who used the Synctuition app for 20-30 minutes daily for 30 days, resulting
COVID-19
Researchers at Shiraz University of Medical Sciences have uncovered the intricate relationships between the COVID-19 pandemic and human ecological footprint. A narrative review published in the Journal of Health Sciences and Surveillance System details how the pandemic has affected various aspects of the environment, including air, water, wastewater, and solid
COVID-19
As the three-year mark of the coronavirus pandemic approaches, resident doctors and nurses at George Washington University Hospital have made the decision to unionize, joining a growing trend of health workers seeking more influence over workplace conditions amidst staffing shortages and burnout. The move follows a grueling winter season that
COVID-19
Research conducted by National Hospital Organization Tokyo National Hospital revealed a significant association between specific human leukocyte antigen (HLA) polymorphisms and the production of antibodies in response to COVID-19 vaccination. The study focused on 87 Japanese rheumatoid arthritis patients who received the BNT162b2 vaccine, finding that certain HLA alleles were
COVID-19
The exclusion of pregnant and breastfeeding individuals from COVID-19 vaccine and clinical trials is a significant concern, particularly given the limited availability of data on the safety and efficacy of these trials in this population. Recent research has highlighted the disparities in trial inclusion and exclusion criteria, with a focus
COVID-19
A new study published in The Journal of Infectious Diseases has provided fresh insights into the effectiveness of the Pfizer-BioNTech COVID-19 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among long-term care facility staff in New York City. The research, conducted by the Epidemic Intelligence Service, found that
COVID-19
Researchers at the Centers for Disease Control and Prevention (CDC) have been investigating a potential connection between the administration of the Pfizer novel coronavirus disease-2019 (COVID-19) bivalent vaccine booster and ischemic stroke (IS) in older adults. A retrospective cohort study was conducted to compare the hazard of IS among patients
COVID-19
Thai general practitioner trainees' participation in online diabetes continuing education (CME) programs remains low, despite the programs offering numerous benefits, particularly during the COVID-19 pandemic. Research conducted at Khon Kaen University revealed that only 40.1% of eligible trainees participated in the study, and among them, only 13.3%
COVID-19
Researchers from Novavax Inc. have published a groundbreaking study on COVID-19 vaccine immunogenicity evaluation, introducing a novel enzyme-linked immunosorbent assay (ELISA) to assess antibody responses against emerging SARS-CoV-2 variants. The study highlights the importance of clinical immunogenicity biomarkers in addressing the growing threat of immune evasion posed by emerging variants.
COVID-19
A recent study conducted at Kadir Has University in Istanbul, Turkey, has found that during the COVID-19 pandemic, consumers' expectations of corporate social responsibility (CSR) have increased significantly. The research, focusing on retail banking, suggests that local brands' CSR actions have a more positive impact on consumer attitudes,
COVID-19
The global coronavirus (COVID-19) current therapy market is experiencing a significant decline due to the Russia-Ukraine war, which has disrupted economic recovery from the COVID-19 pandemic. The market is expected to fall from $28.16 billion in 2021 to $16.43 billion in 2022 at a compound annual growth rate
